Skip to main content
Be The Investor
S&P 500
7,592.06-0.36%
After Hours7,598.79+0.09%
Nasdaq Composite
25,366.09-0.39%
After Hours25,363.64-0.01%
Dow Jones
52,297.09-0.36%
After Hours52,345.00+0.09%
Russell 2000
2,799.06-1.66%
After Hours2,799.96+0.03%
VIX
VIX
18.70+6.92%
Bitcoin
68,717.19-3.72%
Ethereum
1,927.45-4.46%
Solana
78.26-4.16%
Gold
3,913.40+0.72%
Silver
50.23+0.32%
Copper
6.204+0.28%
WTI Crude Oil
88.49-0.24%
US 10-Year Treasury Yield
5.104+2.12%
Home›Stocks›GRCE
OverviewChartNewsFinancialsBusiness ModelCompetitorsStatisticsAnalysisEarningsValuationHoldersOptionsInsidersForecastCompareFAQ

Grace Therapeutics, Inc.

GRCE
NASDAQUnited States flagUSReal-Time Price
$1.81USD
-0.04 (-2.43%)Today
$1.99+0.18 (+10.11%)After HoursLast quote · Nov 11, 2026, 7:30 PM ET · Updates paused

Investors Sentoments

Sign in to share your view.

BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
$55.68M
-31.62% vs fair
Biotechnology
High Risk

Grace Therapeutics, Inc. (GRCE) Business Model

How does Grace Therapeutics, Inc. (GRCE) make money? A breakdown of revenue segments, margins, competitive moat and the unit economics behind the business.

Error loading business model: Sign in to load this business model